N-(2-(3,4-DIMETHYL-1,3-OXAZOL-3-IUM-2-YL)ETHENYL)ANILINE IODIDE
UNII LY7YN4R63F

Substance Identification & Data

This profile provides standardized clinical and technical data for N-(2-(3,4-dimethyl-1,3-oxazol-3-ium-2-yl)ethenyl)aniline Iodide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) LY7YN4R63F.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 21034-17-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

LY7YN4R63F

CAS Registry Number

21034-17-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

N-(2-(3,4-DIMETHYL-1,3-OXAZOL-3-IUM-2-YL)ETHENYL)ANILINE IODIDE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C13H15N2O.I

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

MAQWKZSXWNXMPC-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

159902

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

Cc1coc(/C=C/Nc2ccccc2)[n+]1C.[I-]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for N-(2-(3,4-dimethyl-1,3-oxazol-3-ium-2-yl)ethenyl)aniline Iodide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.